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Evaluation of Pain-Relieving Effect of Menthol and Benzocaine Patches in
Orthodontic Patients: A Triple-Blind Randomized Controlled Trial
Abstract
Purpose
Purpose: This study aimed to compare the effect of benzocaine and menthol patches on pain alleviation
following elastomeric separator placement.
Patients and Methods
Methods: This triple-blind split-mouth trial was conducted on healthy 14-25 years old
patients of orthodontic department. Eligibility criteria included presence of second premolar, first and
second molars in both sides of the mandible, no chronic pain in oral cavity, or chronic consumption of
analgesic drugs. Elastomeric separators were placed mesial and distal of first mandibular molars and
patients were randomized into two groups: 1) menthol/ placebo patches, 2) benzocaine/ placebo
patches. The mucosal patches were placed randomly on the buccal area of mandibular first molars on
both sides. Main outcome was pain level reported by patients on the Visual Analogue Scale (VAS) in
seven-time intervals in three following days. Data were analyzed by linear mixed model. P-value was set to
be 0.05.
Results
Results: Sixty-four patients were randomized in a 1:1 ratio with no loss to follow-up. Both benzocaine and
menthol patches significantly reduced mean pain level compared to placebo patch (P< 0.001).
Benzocaine patch had more analgesic effect; however, the difference was not statistically significant
(P=0.115). Time interval had a significant effect on recorded pain except the first time interval. Age and
gender had no significant effect on pain. No adverse event was reported in patients.
Conclusions
Conclusions: Both benzocaine and menthol patches were effective in alleviating pain. Therefore, they can
be recommended to be used for reducing pain following orthodontic elastomeric separator placement.
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ORIGINAL ARTICLE
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Benzocaine Patches in Orthodontic Patients: A
Triple-blind Randomized Controlled Trial
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f
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ABSTRACT
Purpose: This study aimed to compare the effect of benzocaine and menthol patches on pain alleviation following
elastomeric separator placement.
Patients and methods: This triple-blind split-mouth trial was conducted on healthy 14e25 years old patients of orthodontic department. Eligibility criteria included presence of second premolar, ﬁrst and second molars in both sides of the
mandible, no chronic pain in oral cavity, or chronic consumption of analgesic drugs. Elastomeric separators were placed
mesial and distal of ﬁrst mandibular molars and patients were randomized into two groups: 1) menthol/placebo patches,
2) benzocaine/placebo patches. The mucosal patches were placed randomly on the buccal area of mandibular ﬁrst molars
on both sides. Main outcome was pain level reported by patients on the Visual Analogue Scale (VAS) in seven-time
intervals in three following days. Data were analyzed by linear mixed model. P-value was set to be 0.05.
Results: Sixty-four patients were randomized in a 1:1 ratio with no loss to follow-up. Both benzocaine and menthol
patches signiﬁcantly reduced mean pain level compared to placebo patch (P < 0.001). Benzocaine patch had more
analgesic effect; however, the difference was not statistically signiﬁcant (P ¼ 0.115). Time interval had a signiﬁcant effect
on recorded pain except the ﬁrst time interval. Age and gender had no signiﬁcant effect on pain. No adverse event was
reported in patients.
Conclusions: Both benzocaine and menthol patches were effective in alleviating pain. Therefore, they can be recommended to be used for reducing pain following orthodontic elastomeric separator placement. Taiwanese Journal of
Orthodontics 2022;34(2):81e89
Keywords: Pain; Orthodontics; Benzocaine; Menthol; Visual analog scale

INTRODUCTION

P

atients undergoing orthodontic treatment
experience various degrees of pain after
activating orthodontic appliances and placing
interproximal separators, especially within the
ﬁrst 4 days.1 Using interproximal separators

between ﬁrst molars and second premolars is
mandatory to create enough space for placing
orthodontic bands. Orthodontic pain prevents
correct plaque control and affects overall patient's
satisfaction with the treatment. Previous studies
have shown that orthodontic pain can produce
highly signiﬁcant changes in brain structure and
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The trial follows the declaration of Helsinki and
was approved by Ethics Committee of Hamedan
University
of
Medical
Sciences
(IR.UMSHA.REC.1395.225) and registered at Iran Registry of
Clinical trials with code of (IRCT2016080129155N1).
The inclusion criteria were as follows:

function. Therefore, the orthodontist can increase
patient cooperation with preventing and controlling pain.2e4
A variety of approaches have been introduced to
reduce pain during orthodontic treatment: oral
NSAIDs, local use of anesthetic gels, chewing gum
or biting wafer, laser, and vibratory stimulation.5e7
However, none of these methods have been proved
to be the right solution.
Benzocaine is a local anesthetic drug utilized in
dentistry and minor surgeries. It has no negative
effect on tooth movement and causes minimal systemic side effects. In some studies, benzocaine has
been applied for relieving orthodontic treatment
pain and reducing mucosal irritation.8e12
Menthol, an extracted material from mint (Mentha
piperita), is a local anesthetic agent that has been
used as menthol patch and gel in treating painful
conditions such as allodynia, migraine, musculoskeletal pain, neuropathy, and sports injuries.13e15
Considering the fact that placing separator is carried
out in the commencement of treatment and is usually
accompanied by pain, reducing pain in this step can be
radically inﬂuential in motivating patients and
lowering their stress for orthodontic treatment. Side
effects of systemic drugs made present authors search
for a modern and accurate method of controlling pain
introducing a local anti-pain drug to reduce pain
which is less irritating for patients. The purpose of this
study was to compare the effect of benzocaine and
menthol patches to reduce pain after placement of
elastomeric separators.

1. No pain in the region of mouth at the beginning
of the study
2. Presence of moderate crowding (4e8 mm) in
mandibular arch
3. Presence of ﬁrst molars, second molars, and
second premolars of mandible with tight interproximal contacts.
The exclusion criteria were as follows:
1.
2.
3.
4.
5.

Pregnancy
History of liver or kidney disease
History of allergy to local anesthetic drugs
History of methemoglobinemia
Chronic consumption of NSAIDS, sedatives, or
other analgesic drugs

Study protocol was explained to patients and
informed consent was obtained from patients or
their representative authorities.
Patients were randomly categorized into two
groups. Stratiﬁed randomization according to age
and gender was done with the aid of www.
sealedenvelope.com. The samples were divided
into subgroups according to age (14e18 years old
versus 18e25 years old) and gender (female versus
male). The samples were chosen randomly from
these subgroups. A list of numbers was prepared
and written in opaque envelopes. Patients were
asked to take an envelope from a container. The
number in the envelop deﬁned the assigned group
of the patient (benzocaine/placebo or menthol/placebo) and the side of patch placement (right or left).
Allocation concealment, sequence generation, and
patient enrollment were done by three authors (SS,
FD, SS, respectively).
The study was designed to be triple-blind.
Benzocaine, menthol, and placebo patches had a
completely similar appearance. The patients, the
operator, and the outcome assessor were not aware
of the type of patch on each side.
Elastomeric separators (Dentarum, Springen,
Germany) were placed in mesial and distal contacts
of ﬁrst mandibular molars. The ﬁrst group
randomly used menthol patch on one side and
placebo patch on the other side of lower arch. The
second group used benzocaine and placebo patches,
randomly on each side of lower arch. Placement

MATERIALS AND METHODS
This randomized split-mouth controlled tripleblind clinical trial with a 1:1 allocation ratio was
carried out using split-mouth design on 64 patients
(25 males, 39 females), 14e25 years old, in the orthodontic department of dental school of Hamedan
University of Medical Sciences from 2017 to 2019.
The sample size was calculated by PWR package
in R-software according to the ﬁnding of Eslamian
et al.9 In this research, the effect of benzocaine and
placebo mucoadhesive patches on pain caused by
elastomeric separators were compared. Perceived
pain at 72 h were 0.97 ± 0.85 and 1.67 ± 0.92 in
benzocaine and placebo patches, respectively. Expected mean and standard deviation were calculated from the data reported by this article.
Considering 5% alpha error, 80% statistical power,
standard deviation of 1.27, 20% lost to follow up, and
to ﬁnd a difference of 0.7 in mean pain, a total
sample size of 64 was measured (32 in each group).
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method was taught to patients so that they place half
of the patch on tooth and half over the attached
gingiva of mandibular permanent ﬁrst molar
(Figure 1). The patches remained in place until they
resolved. The patients were asked to use the ﬁrst
patch immediately after placing separator, and if
needed, repeat this process every 6 h for three days.
The patches had the size of 1.5 cm * 1.5 cm and were
produced under the supervision of a pharmaceutical
consultant. Benzocaine patch contained 20 mg
benzocaine (equal to one puff of 20% benzocaine
spray),9 and menthol patch contained 20 mg
menthol. In addition, the patches consisted of
dichloromethane, polyvinyl pyrrolidone, propylene
glycol, ethanol, hydroxyl propylene methylcellulose,
and aspartame. The patients were asked to avoid
consuming any analgesic drugs during the study
protocol and if unavoidable, they could use acetaminophen 325 mg and should mention this in the
questionnaire. They were instructed to ﬁll out a
questionnaire made by visual analogue scale,
involving 0 to 10 scores for level of pain in time
intervals of 2, 6, 12, 24, 36, 48, and 72 h after placing
interproximal separators. These time intervals were
provided in previous studies and involve recorded
times for maximum intensity of pain.16 Taking
analgesic drugs during study period (except for
325 mg Acetaminophen which was mentioned in the
questionnaire), patients’ incompliance in ﬁlling out
the questionnaire or self-declaration of not
consuming the patches, as well as, separator coming
out during study period led to exclusion of the patient after trial commencement.

Data was analyzed by SPSS software, version 23
(IBM, Armonk, NY). Means and standard deviation
of pain were measured at different time intervals in
each group. Linear Mixed Model (LMM) analyses
were performed to investigate the effect of patch
type, time interval, age, and gender on perceived
pain. In this analysis, participant was treated as a
random effect to group the data per participant. This
means that the same participant was measured
multiple times. In other words, the intercept is not
constant and is a random variable, i.e. the intercept
varies between persons. Person characteristics, such
as age (in two groups of less than 18 years old and
more than 18 years old) and gender, were also added
to control for these variables. Data of placebo patches
in both groups of patients were pooled as the control
group. In this analysis, for each variable, a factor was
considered as reference category and the other factors were compared to it. We considered the control
group, male gender, age over 18 years old, and 7th
time interval as reference categories. The statistically
signiﬁcant difference was set at P < 0.05.
The effect of type of patches on perceived pain
were compared with Bonferroni adjustment for
multiple comparisons to account for type 1 error.
Since we had three comparisons, signiﬁcance level
would be divided by three; i.e. 0.05/3 ¼ 0.016. This
was automatically addressed in measured P-value of
analysis by SPSS software.

RESULTS
Seventy-three orthodontic patients were enrolled
in the study from April 2019 up to June 2020, nine of
the patients were excluded according to eligibility
criteria. Figure 2 shows the process of participant
selection.
None of the patients reported consumption of
Acetaminophen or other analgesics. Using of
patches had no signiﬁcant adverse effect or
complication. None of the separators came out
during study. All of the patients applied the patches
as instructed and ﬁlled out the questionnaire.
Demographic data of participants are shown in
Table 1. Gender and age distributions were similar
in all groups. Chi-square test showed no signiﬁcant
statistical difference in age and gender between
groups (P value < 0.34 and P value < 0.61,
respectively).
Results of descriptive analysis, including mean,
standard deviation, and 95% conﬁdence interval of
pain in studied groups at different time intervals are
shown in Table 2, Figure 3A and B compare the
effect of menthol/placebo patches and benzocaine/
placebo patches, respectively.

Figure 1. A patch placed on lower ﬁrst mandibular molar. Half of the
patch is on the gingiva. The saliva and the slightly sticky nature of the
patches, caused the initial stability of the patch over the tooth and
gingiva.
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Figure 2. Flow diagram of trial participant recruitment.

Table 3 shows the results of linear mixed model.
In this analysis, both placebo groups were pooled
and a single control group was considered.
Figure 3C shows the trend of changes in different
time intervals in three studied groups.
In Figure 3, each factor is compared to its reference category. Placebo group was considered as

reference category to evaluate the effect of patch
type on perceived pain. The perceived pain was less
in both menthol and benzocaine groups compared
to placebo group (reference category) and the differences were statistically signiﬁcant (p < 0.001,
P < 0.001, respectively). Although benzocaine patch
caused more analgesic effect than menthol patch,
according to adjustment for multiple comparison
Bonferroni analysis the difference between these
two groups was not statistically signiﬁcant
(P ¼ 0.115). Mean recorded pain in menthol,
benzocaine and control groups were 1.86 (standard
error ¼ 0.18), 1.47 (standard error ¼ 0.18), 2.75
(standard error ¼ 0.16), respectively (Tables 4 and 5).
Seventh time interval was considered as reference
category to assess the effect of time intervals.

Table 1. Demographic data of study participants.
Group

MentholPlacebo
BenzocainPlacebo

14e18
years old

18e25
years old

Age
(Mean ± SD)

Female

Male

Female

Male

10

9

9

4

18.97 ± 2.94

11

8

6

7

17.87 ± 3.74
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Table 2. Mean and standard deviation of perceived pain in study groups
at different follow up times.
Time interval Mean pain± SD
95% CIa
Lower boundUpper bound

1
2
3
4
5
6
7
a

Furthermore, mucosal patches increased the time
that the drug is in contact with the tissue.19
Although the duration of anesthetic effect of
benzocaine is short, it is possible that the agent is
able to break the pain cycle and thus, be effective in
consistent pain reduction. Cooper et al. have
observed that after commencement of pain, many
factors (i.e psychologic and physiologic) can exacerbate pain perception. Breaking this pain cycle can
avoid increased pain perception.20 This result is
similar to Eslamian et al.9 In her study with splitmouth method, the effect of benzocaine and placebo
patches in reducing pain following elastomeric
separator placement was compared. She found that
less pain was experienced in the Benzocaine side.9
In the study of Hersh et al., mucosal patch with
12 mg benzocaine was applied to decrease instantaneous dental pains and it was found that more
percentage of patients reported pain relief with
benzocaine patch than placebo.21
It was found that applying menthol patches
resulted in statistically signiﬁcant lower pain scores
than placebo. These ﬁndings suggest that using
benzocaine and menthol patches are efﬁcient
pharmaceutical methods to reduce orthodontic pain
resulted from placement of elastomeric separators.
Benzocaine patch had more anti-pain effect than
menthol patch. However, the difference was not
statistically signiﬁcant. Menthol is an agonist of
Transient Receptor Potential Melastatin-8 (TRMP8)
receptor, known as menthol receptor. These receptors are found in thermosensitive neurons and
they became sensitized due to exposure to menthol,
leading to coolness perception and inhibition of
pain impulse conduction. Menthol may cause
blockage of sodium channels.14,15 Evidence
regarding its vasoactive effect is contradictory, some
support its vasodilation and increased blood ﬂow
effect,15 and others claim that menthol causes
reduced blood ﬂow.22 Cooling effect, sodium channel blockage, and possible vasodilation mechanisms
can explain its potential in decreasing orthodontic
pain. Sodium channel blockage by menthol is
weak.15 This can explain weaker analgesic effect of
menthol compared to benzocaine. Although the
anti-pain effect of menthol is proved in many
studies,13e15,23 no research is available with respect
to applying menthol for reducing pain from orthodontic treatment. Naganawa et al. evaluated topical
application of capsaicin, menthol, and local anesthetics on intraoral somatosensory sensitivity. They
applied these drugs on the gingiva and used mechanical and thermal stimuli on that area. They
found no signiﬁcant difference in pain scores between menthol and control groups.24 However, in

Mean pain± SD
95% CIa
Lower boundUpper bound

Menthol

Placebo

Benzocaine Placebo

1.3 ± 1.35
0.54_ 1.52
2.06 ± 1.34
1.58_ 2.55
2.69 ± 1.84
2.02_ 3.35
2.31 ± 2.16
1.53_ 3.09
2.47 ± 2.38
1.61_ 3.33
2.03 ± 2.21
1.23_ 2.83
1.37 ± 1.68
0.77_ 1.98

0.97 ± 0.97
0.62_ 1.32
4 ± 1.83
3.34_ 4.66
4.59 ± 2.11
3.83_ 5.35
3.66 ± 2.36
2.80_ 4.51
2.87 ± 2.31
2.04- 3.71
2.47 ± 2.05
1.73_ 3.21
1.87 ± 1.91
1.18_ 2.56

0.97 ± 0.78
0.69_ 1.25
1.5 ± 0.72
1.24_ 1.75
2.09 ± 1.30
1.62_ 2.56
2.06 ± 2.06
1.32_ 2.81
1.25 ± 1.92
0.56_ 1.94
0.94 ± 1.7
0.32_ 1.55
0.81 ± 1.65
0.21_ 1.41

1.69 ± 0.99
1.33_ 2.05
3.43 ± 1.60
2.86_ 4.02
3.81 ± 1.71
3.19_ 4.43
3.72 ± 2.08
2.97_ 4.47
2.69 ± 2.25
1.88_ 3.50
1.66 ± 2.12
0.89_ 2.42
1.37 ± 1.96
0.67_ 2.08

Conﬁdence interval.

Perceived pain in the second, third, fourth, ﬁfth, and
sixth time intervals showed statistically signiﬁcant
difference compared to the seventh time interval
(reference category) (P < 0.001). In all three groups,
maximum pain was recorded at the third time interval (12 h after placing separator). Pain was not
signiﬁcantly different between the ﬁrst and the
seventh time intervals.
Linear mixed model showed that gender and age
did not have a signiﬁcant effect on changes in
perceived pain.

DISCUSSION
The present study evaluated the effect of benzocaine and menthol patches on pain reduction using
VAS at 2, 6, 12, 24, 36, and 72 h after orthodontics
elastomeric separator placement. The results
showed that benzocaine group had statistically signiﬁcant lower pain score compared to the placebo
group. Anesthetic effect with 20% benzocaine usually starts within 30 s and lasts for up to 15 min.
Topical application of this agent is effective in inhibition of pain in superﬁcial tissues.17 In contrast to
other local anesthetic drugs, benzocaine can act in
environments with low pH.18 This can explain why
the drug is effective in low pH environment of
orthodontically moved teeth. In the present study,
benzocaine patches with 20% concentration were
applied on the tooth and gingiva, covering the
gingival sulcus. It is possible that benzocaine can be
absorbed by PDL via gingival crevicular ﬂuid. Since
the origin of orthodontic pain is PDL, this topical
application may be effective in pain management.
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Figure 3. Line graph indicating mean level of pain (mean pain) in study groups at all time intervals (horizontal axis: 1: 2 h, 2: 6 h, 3: 12 h, 4: 24 h, 5:
36 h, 6: 48 h, 7: 72 h). A. Menthol and placebo patches; B. Benzocaine and placebo patches; C, Menthol, benzocaine, and placebo patches.
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Table 3. Results of linear mixed model on effect of patch type, time interval, age and gender effect on recorded pain.
Parameter

Mean difference

Intercept
Menthol patch
Benzocaine patch
Control patch (reference category)
Time 1
Time 2
Time 3
Time 4
Time 5
Time 6
Time 7 (reference category)
Age (<18 years old)
Age (>18 years old)
(reference category)
Female
Male (reference category)

Standard error

Lower Bound

Upper Bound

0.30
0.14
0.14
e
0.19
0.19
0.19
0.19
0.19
0.19
e
0.29
e

0.001
0.001
0.001
e
0.298
0.001
0.001
0.001
0.001
0.027
e
0.412
e

1.17
1.16
1.55
e
0.56
1.02
1.57
1.21
0.59
0.05
e
0.33
e

2.38
0.62
1.01
e
0.17
1.76
2.30
1.95
1.33
0.78
e
0.81
e

0.02
e

0.28
e

0.927
e

0.57
e

0.52
e

separator, and it follows a non-linear form in a
quadratic shape. However, the maximum pain in this
study was in the morning of the ﬁrst day or 24 h after
placing separator.26 Maximum level of pain in Eslamian et al. study was 24 h after placing separator.9
According to Giannopoulou et al., level of pain increases from one to 24 h following placing separator.27 The multifactorial and subjective nature of
pain, different age ranges of the participants, and
using different types of separators could inﬂuence
the results and this could be the reason for difference
in the time of maximum pain in different studies.
Pain assessment was done by Visual Analogue
Scale (VAS). VAS is a non-verbal, valid, reliable,
reproducible, easily accessible, and sensitive
method. In addition, because of its illustrative platform and minimal dependence on language, results
of different studies in various cultures can be
compared easily.28 Although being precise, some
authors stated that its unidirectional, linear nature
leads to errors in differentiating between sensory
and afferent (unpleasant) aspects of pain.29 Thus,
some researchers believe that measuring chemical
messengers of pain is a better method. Interleukin1b is the primary mediator to regulate bone
remodeling in response to orthodontic forces and
plays an important role in responding to
Table 5. Pairwise comparison of patches based on Bonferroni adjustment for comparisons.

Table 4. Estimated marginal means of recorded pain based on the linear
mixed model.
Mean Std. Error 95% Conﬁdence Interval
Lower Bound Upper Bound
0.182
0.183
0.155

95% Conﬁdence Interval

1.78
0.89
1.28
e
0.19
1.39
1.94
1.58
0.96
0.41
e
0.24
e

the present study, type of pain inducing stimulus
(tooth movement) and design of the study (splitmouth) are different from Naganawa et al.’s
research.
Considering mean of pain in two elastomeric
separator groups, the results indicated that pain
increases following placing separator and reaches to
its maximum in the third time interval (12 h after
placing separator) and ﬁnally falls down. In the
seventh time interval (third day), some patients still
reported pain. Studying ﬂow of pain showed that
pain from elastomeric separator is not linear and
followed a quadratic pattern (Figure 3). When the
separator is placed, the vessels on the compression
side are squeezed and ischemia occurs, causing
anaerobic respiration and acidosis. Acid-sensing ion
channel 3 (ASIC 3) is an ion channel receptor in
periodontal tissue and recognizes both acidity
changes and mechanical forces and transduces
them to painful signals. When the force is kept
minimal, the mechanosensation role is not signiﬁcant. So that, early hours following force application,
perceived pain is minimal. Local inﬂammation occurs in 12 h. This phenomenon explains the fact that
most patients experience the maximal pain level at
approximately 12 h.25
Similar to this ﬁnding, Sandhu et al. showed that
pain starts almost one hour following placing

Benzocaine patch 1.47
Menthol patch
1.86
Control patch
2.75

P value

1.110
1.500
2.443

1.831
2.224
3.062

87

First groups

Second
group

Mean
difference

Standard
error

P value

Benzocaine
patch
Menthol
patch

Menthol patch
Placebo patch
Placebo patch

0.392
1.289
0.899

0.189
0.189
0.138

0.115
0.0001
0.0001
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orthodontic pains. Previous studies showed that
concentration of IL-1b promoted after one hour of
applying force, the maximum of IL-1b was seen after
24 h, and it reduced to its normal level after one
week.30,31 So that, level of this chemical agent can
act as a measure of pain intensity. However,
Gameiro et al., have stated that level of IL-1b is not
necessarily correlated with intensity of experience
pain.32 Therefore, more studies are required to
evaluate the precise correlation between level of IL1b and subjective pain scores.
Multiple factors can affect pain perception,
including age and gender. Some authors have reported that females and adolescents express more
pain compared to males and pre-adolescents and
adults, respectively.33 However, evidence regarding
this issue is quite contradictory. Many studies
showed no signiﬁcant difference between males and
females in pain expression.8,9,11,12 In addition, some
authors reported that orthodontic pain perception is
not affected by patient's age.34 In order to eliminate
these possible confounding variables, in the present
study random sampling was applied by matching
age and gender in studied groups.
Pain is a mental reaction to nervous stimulants
whose intensity depends on personal differences,
sleeping quality, physiologic conditions, genetics,
hormonal differences, and previous painful experience.6,16 In this study, it is tried to minimize the
effects of these factors using a randomized clinical
trial method of split-mouth and high volume of
samples.
Considering the fact that pain is a subjective issue
and shows great interpersonal variability, splitmouth design was chosen for this study. It has been
shown that split-mouth design can decrease interpersonal variations.35,36 Nevertheless, this design
may have some problems. Hujoel et al. have reported three potential problems of this design: (1)
presence of carry-across effect (i.e. the intervention
in one side can affect the other side); (2) difﬁculty of
ﬁnding samples with similar conditions on both
sides; (3) being more efﬁcient than parallel design
only in cases that within-patient correlation coefﬁcient is high.37e39 In this study, ﬁnding patients with
intact dentition in mandible was not a problem. In
addition, interpersonal differences in pain perception are substantial. However, carry-across effect is a
possible problem. To decrease this problem, we
designed the present study in a way that two active
interventions (menthol and benzocaine) are given to
different people (parallel design), but to decrease
interpersonal differences in pain perception, one
side in each patient was chosen as placebo (split
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mouth). Afterwards, patches effects are mainly
topical. However, solubility in saliva is still possible
and cannot be neglected. It is suggested that in
future studies, unidirectional patches be administrated. These patches release the drug from only one
side.19
In present study, patches were chosen as a
method of drug delivery. Patches are suitable carriers for drugs in oral cavity since there is extensive
smooth, immobile mucosa to retain the patch.
Capability of delivering the drug to affected area
(topical action), reaching the desired dose in the site,
and retaining for a more prolonged time are advantages of patches over some other traditional
methods. Patches should be elastic, ﬂexible, and
have good tear resistance.19 These characteristics
were considered during patch production in present
study. None of the patients in the present study
reported adverse reactions related to patches.
The main limitations of this study were difﬁculty
in persuading patients in terms of accurate use of
patches and ﬁlling out questionnaires in determined
times, limited number of articles investigating
menthol, especially in dentistry ﬁeld, and impossibility of direct and precise measurement of pain
regarding subjective and personal nature of it. Due
to lack of enough studies regarding use of menthol
patches in reducing orthodontic pain, it is suggested
that more research should be done on the effect of
this material on different stages of orthodontic
treatment with various concentrations and applying
protocols.
In conclusion, menthol and benzocaine patches
have been signiﬁcantly effective in reducing pain
resulted from elastomeric separators and both of
them could be used as an analgesic agent after
placing elastomeric separators. Although benzocaine patch was superior to menthol patch in
relieving pain, this difference was not statistically
signiﬁcant.
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